AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/23/2024 | Press release | Distributed by Public on 05/23/2024 07:53
Please select the service you want to use:
Smartlinks | Dell Inc. | Dell Technologies Inc. | News | Local News | Company News | Computer Hardware Manufacturers | Securities Issuers | Private Companies | Corporate Debt Issuers
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact